Article
Inhibiting epigenetic enzymes to improve atherogenic macrophage functions.
Biochemical and biophysical research communications - 12 Dec 2014
Van den Bossche Jan, Neele Annette E, Hoeksema Marten A, de Heij Femke, Boshuizen Marieke C S, van der Velden Saskia, de Boer Vincent C, Reedquist Kris A, de Winther Menno P J
Abstract excerpt
Macrophages determine the outcome of atherosclerosis by propagating inflammatory responses, foam cell formation and eventually necrotic core development. Yet, the pathways that regulate their atherogenic functions remain ill-defined. It is now apparent that chromatin remodeling chromatin modifying enzymes (CME) governs immune responses but it remains unclear to what extent they control atherogenic macrophage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
